Successful kidney transplantation offers patients with end-stage renal disease the greatest
likelihood of survival. However, cardiovascular disease poses a major threat to both graft …

The increased utilization of high-risk renal grafts for transplantation requires optimization of
pretransplant organ assessment strategies. Current decision-making methods to accept an …

In the Belatacept Evaluation of Nephroprotection and Efficacy as First-Line
Immunosuppression Trial–Extended Criteria Donors (BENEFIT-EXT), extended criteria …

Mesenchymal stromal cells (MSCs) exhibit anti-inflammatory and immune-regulatory
properties, and preclinical studies suggest a potential benefit in solid organ transplantation …

Background The aim of this study is to present average annual healthcare costs for Dutch
renal replacement therapy (RRT) patients for 7 treatment modalities. Methods Health …

Background In the last few decades, strategies to improve allograft survival after kidney
transplantation have been directed to recipient-dependent mechanisms of renal injury. In …

The targeted delivery of therapeutic drugs to lymph nodes (LNs) provides an unprecedented
opportunity to improve the outcomes of transplantation and immune-mediated diseases. The …

Owing to improvements in catheters and embolic agents, renal artery embolization (RAE) is
increasingly used to treat nephrological and urological disease. RAE has become a useful …

Background Early after renal transplantation, it is often challenging to achieve and maintain
tacrolimus concentrations within the target range. Computerized dose individualization …

The medical device M101 is an extracellular hemoglobin featuring high oxygen-carrying
capabilities. Preclinical studies demonstrated its safety as an additive to organ preservation …